Psoriasis Clinical Trial

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis

Summary

This is a study to evaluate pharmacokinetics (PK), safety and tolerability of ABBV-157 in healthy volunteers and in participants with chronic plaque psoriasis, and to evaluate the efficacy of ABBV-157 in the participants with psoriasis. This study consists of two substudies. Substudy 1 is a randomized, double-blind, placebo-controlled evaluation of multiple ascending oral doses of ABBV-157 in healthy adult volunteers. Substudy 2 is a randomized, double-blind, placebo-controlled study in which participants with moderate to severe chronic plaque psoriasis will be administered multiple oral doses of ABBV-157.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Volunteer should be between 18 and 55 years of age and in general good health for Substudy 1 and participant with moderate to severe chronic plaque psoriasis between 18 and 75 years of age for Substudy 2 at the time of enrollment.
Participant should meet the laboratory assessments as mentioned in the protocol.

Exclusion Criteria:

Participant has a history of epilepsy, any significant cardiac, respiratory, renal, hepatic, gastrointestinal, opthalmologic, hematologic,or psychiatric disease or disorder, or any uncontrolled medical illness.

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

65

Study ID:

NCT03922607

Recruitment Status:

Completed

Sponsor:

AbbVie

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 10 Locations for this study

See Locations Near You

Total Skin and Beauty Derm Ctr /ID# 222593
Birmingham Alabama, 35205, United States
Alliance Dermatology and MOHs /ID# 222622
Phoenix Arizona, 85032, United States
Anaheim Clinical Trials LLC /ID# 213645
Anaheim California, 92801, United States
Dermatology Res. Assoc., CA /ID# 224980
Los Angeles California, 90045, United States
Providence Clinical Research /ID# 213339
North Hollywood California, 91606, United States
Advanced Medical Research /ID# 216090
Sandy Springs Georgia, 30328, United States
Acpru /Id# 213639
Grayslake Illinois, 60030, United States
University of Pittsburgh MC /ID# 224699
Pittsburgh Pennsylvania, 15260, United States
PPD PH I Clinical Unit /ID# 213062
Austin Texas, 78744, United States
Center for Clinical Studies - Webster TX /ID# 217352
Webster Texas, 77598, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

65

Study ID:

NCT03922607

Recruitment Status:

Completed

Sponsor:


AbbVie

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider